Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ) just unveiled an update.
Guangdong Kanghua Healthcare Group Co., Ltd. announced a change in its board of directors, with Mr. Lv Yubo resigning as a non-executive director to focus on other endeavors, and Mr. Jiang Xiwen being appointed as his replacement effective October 17, 2025. Mr. Jiang, a well-credentialed professional with a background in microbiology and leadership roles in medical device associations, will bring his expertise to the company, potentially impacting its strategic direction and stakeholder relations positively.
The most recent analyst rating on (HK:3689) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a joint stock company incorporated in China, operating in the healthcare industry. The company, along with its subsidiaries, focuses on providing healthcare services and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 29,750
Technical Sentiment Signal: Hold
Current Market Cap: HK$662.1M
For a thorough assessment of 3689 stock, go to TipRanks’ Stock Analysis page.